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Abstract 
Background: Rational engineering studies for deoxycytidine production were initiated due to low intracellular 
levels and tight regulation. To achieve high‑level production of deoxycytidine, a useful precursor of decitabine, genes 
related to feed‑back inhibition as well as the biosynthetic pathway were engineered. Additionally, we predicted the 
impact of individual gene expression levels on a complex metabolic network by microarray analysis. Based on these 
findings, we demonstrated rational metabolic engineering strategies capable of producing deoxycytidine.
Results: To prepare the deoxycytidine producing strain, we first deleted 3 degradation enzymes in the salvage path‑
way (deoA, udp, and deoD) and 4 enzymes involved in the branching pathway (dcd, cdd, codA and thyA) to completely 
eliminate degradation of deoxycytidine. Second, purR, pepA and argR were knocked out to prevent feedback inhibi‑
tion of CarAB. Third, to enhance influx to deoxycytidine, we investigated combinatorial expression of pyrG, T4 nrdCAB 
and yfbR. The best strain carried pETGY (pyrG‑yfbR) from the possible combinatorial plasmids. The resulting strain 
showed high deoxycytidine yield (650 mg/L) but co‑produced byproducts. To further improve deoxycytidine yield 
and reduce byproduct formation, pgi was disrupted to generate a sufficient supply of NADPH and ribose. Overall, in 
shake‑flask cultures, the resulting strain produced 967 mg/L of dCyd with decreased byproducts.
Conclusions: We demonstrated that deoxycytidine could be readily achieved by recombineering with biosynthetic 
genes and regulatory genes, which appeared to enhance the supply of precursors for synthesis of carbamoyl phos‑
phate, based on transcriptome analysis. In addition, we showed that carbon flux rerouting, by disrupting pgi,  
efficiently improved deoxycytidine yield and decreased byproduct content.
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Background
Deoxycytidine (dCyd) is a commercially useful precur-
sor in the chemical synthesis of various drugs including 
decitabine (Dacogen™, 5-aza-2′-deoxycytidine), which is 
used to treat myelodysplastic syndromes, a class of con-
ditions where certain blood cells are dysfunctional, and 
for acute myeloid leukemia [1, 2]. A similar analogue, 
azacitidine (5-aza-2′cytidine) derived from cytidine (Cyd) 
is also used for this purpose [3]. However, because azac-
itidine is a potential substrate for the DNA replication 
machinery after metabolism to its deoxy derivative, there 
are subtle differences in efficacy between azacitidine and 
decitabine. A recent report described the production of 
Cyd by rationally engineered Escherichia coli, in which 
pentose phosphate pathway (PPP) genes were ampli-
fied to supply precursor [4]. And Zhu et al. also reported 
the production of Cyd by deregulation of the pyr operon 
and the overexpression of the prs, pyrG and pyrH genes 
in Bacillus subtilis [5]. In contrast, so far, the studies for 
dCyd production have not been achieved by rational 
engineering, due to low intracellular levels and tight 
gene regulation. To date, dCyd production has only been 
achieved by traditional engineering employing bacteria 
belonging to the genera Corynebacterium [6]. However, 
while dCyd production by rational engineering is not well 
studied, another pyrimidine deoxynucleoside, thymidine, 
has been studied actively [7–11]. In previous work, we 
showed that deletion of three repressors (purR, pepA and 
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argR) involved in the regulation of carbamoyl phosphate 
synthetase (carA/carB), positively affected thymidine 
production [7]. To enhance the reduction of nucleo-
tides, we overexpressed T4 NDP reductase subunits. In 
an effort to develop a new deoxy pyrimidine nucleoside-
producing strain that might spawn similar engineer-
ing towards development of a thymidine producer, we 
focused on dCyd production by E. coli.
As illustrated in Figure  1, de novo biosynthesis of 
dUMP occurs through two distinct pathways in pyrimi-
dine biosynthesis [12, 13]. The quantitatively more 
important pathway involves the deamination of dCTP to 
dUTP by dCTP deaminase, followed by the hydrolysis of 
dUTP by dUTP nucleotidohydrolase (dUTPase) to yield 
dUMP with 75% of endogenous dUMP arising through 
this route. The second pathway generating the remaining 
25% of dUMP consists of the reduction of UDP by rib-
onucleoside diphosphate reductase to dUDP, which is 
phosphorylated by nucleoside diphosphokinase (encoded 
by ndk) to dUTP and subsequently hydrolyzed to dUMP 
by dUTPase [14]. Alternatively, dUMP may be produced 
by pyrimidine salvage through reaction of deoxyuridine 
with thymidine kinase. The deoxyuridine, in turn, may 
arise either from dCyd through deamination catalyzed by 
Cyd (dCyd) deaminase (encoded by cdd) or by the con-
densation of uracil and deoxyribose 1-phosphoate medi-
ated by thymidine phosphorylase (encoded by deoA), 
although this latter reaction is believed to act predomi-
nantly in the catabolic direction [13, 15]. As explained 
here, most of the dCTP biosynthetic pathway has shared 
pathways with dTTP biosynthesis, but dCTP is synthe-





















































































Figure 1 The deoxycytidine biosynthetic pathway. The steps engineered in this study are indicated by the bold arrows and lines. Components 
of the catabolic pathways are as follows: carAB carbamoyl phosphate synthase, pyrBI aspartate‑carbamoyl transferase, pyrC dihydroorotase, pyrD 
dihydroorotate oxidase, pyrE orotate phosphoribosyl transferase, pyrF OMP decarboxylase, pyrG CTP synthetase, pyrH UMP kinase, yfbR dCMP 
phosphohydrolase, nrdCAB nucleotide diphosphate reductase, thyA thymidylate synthase, dcd dCTP deaminase, udk uridine kinase, deoA thymidine 
phosphorylase, tdk thymidine kinase, udp uridine phosphorylase, dut deoxyribonucleotide triphosphatase, ndk nucleotide diphosphate kinase, tmk 
TMP kinase, cdd cytidine deaminase, codA cytosine deaminase, deoD purine nucleoside phosphorylase, rihA, rihB ribosyl pyrimidine nucleosidase, 
cmk cytidylate kinase, purR purine repressor, pepA aminopeptidase A, argR arginine repressor.
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In this study, CTP synthetase (encoded by pyrG) and 
T4 NDP reductase (encoded by nrdCAB) were overex-
pressed to increase dCMP pools. While a highly specific 
dCMP phosphohydrolase was needed to generate dCyd 
from increased dCMP, all 5′-nucleotidases studied so far 
are enzymes with broad specificity on NMP and dNMP 
(e.g. those encoded by ushA, surE, yjjG and yfbR) [16]. 
Especially, UshA and SurE are active on only NMP, with 
no apparent activity on dNMP. YjjG, known as the house-
cleaning enzyme, catalyzes CMP, dUMP and dTMP as 
substrates but not dCMP [17]. In contrast, YfbR uses 
dCMP as a substrate but prefers other dNMPs, exhibiting 
higher activity on dGMP, dUMP and dAMP than dCMP 
[18]. In particular, the activity on dUMP of E. coli yfbR 
is higher than dCMP by 1.5-fold (dGMP > dUMP > dAM
P  >  dCMP  >  GMP  >  dTMP  >  NMPs) [19]. Other than 
purine nucleotides, the higher activity of YfbR on dUMP 
may be problematic, because dUMP can be increased 
proportionally with dCMP. Among 5′-nucleotidases 
studied so far, however, YfbR is the best available candi-
date, as, to date, no highly specific dCMP phosphohydro-
lase has been identified or engineered.
Based on the information known about nucleotide bio-
synthesis and our experience developing thymidine pro-
ducing strains, we prepared a novel dCyd-producing strain 
by rational metabolic reprogramming. Our approach, 
first, involved the deletion of known nucleoside degrading 
enzymes and branching enzymes, followed by the deletion 
of the thymidylate synthase gene (thyA). Next, to enhance 
influx to pyrimidine, the genes encoding the CarAB repres-
sors were deleted and the bottleneck enzymes (NDP reduc-
tase, CTP synthetase and dCMP phosphohydrolase) were 
overexpressed. In this approach, unwanted problems may 
arise from increasing unexpected byproducts and los-
ing control of the biosynthesis of purine, pyrimidine and 
arginine, which may affect cell growth and maintenance. 
Because purine and pyrimidine nucleotides constitute 
components of nucleic acids, cofactors in enzymatic reac-
tions, intracellular and extracellular signals, phosphate 
donors, and the major carriers of cellular energy, imbalances 
between these different nucleotide pools can significantly 
perturb normal cellular function [20–22]. Here, we analyzed 
metabolic change by partial transcriptome microarray and 
investigated byproduct profiles of the strain derivatives gen-
erated at each engineering stage. Based on these findings, 
we demonstrated the use of rational metabolic engineering 
of E. coli to produce dCyd with less byproducts formation.
Results
The deletion of salvage and branching pathway genes 
in cells with high dCyd resistance
E. coli DeoA, Udp and DeoD have essential roles in 
pyrimidine nucleotide salvage pathways and are known 
to catalyze reversible reactions [9, 12]. Hence, these 
nucleoside phosphatases might have potential roles in 
the degradation of intracellular dCyd. Using a high con-
centration of dCyd resistant strain (up to 10  g/L, Addi-
tional file 1: Figure S1), deoA, udp and deoD were deleted 
sequentially by PCR-mediated disruption to construct 
HLC003 (Additional file  1: Figure S2A). If overall phos-
phatase activity of any unidentified pathway members is 
less than the contribution of these three enzymes (DeoA, 
Udp and DeoD) to the salvage pathway, the deletion of 
deoA, udp and deoD should be enough to prevent degra-
dation of dCyd in at least low dCyd-producing cells. To 
test this notion, an in vitro dCyd degradation assay was 
carried out for evaluation. The assay profile, however, 
showed that, during the time tested, dCyd degradation 
in  vitro was apparently not completely blocked by dis-
rupting deoA, udp and deoD (Figure 2), perhaps because 
dCyd degradation is closely linked to the conversion steps 
of dCTP, dCyd and cytosine into dUMP, deoxyuridine 
and uracil, respectively [12]. Hence, this suggested the 
branching nodes into other nucleotide pathways would 
be good targets for further strain engineering to increase 
dCyd influx by blocking additional dCyd degradation. 
Based on the nucleotide synthetic pathway, dcd, cdd and 
codA, which encode enzymes that catalyze deamination 
of dCTP, dCyd and cytosine, respectively, were disrupted 
step-by-step, resulting in HLC006. Additionally, thyA, 
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Figure 2 Deoxycytidine degradation assay. To eliminate possible 
degradation of dCyd which was produced during fermentation, 
known pyrimidine nucleoside degradation enzymes were disrupted. 
The disruption of deoA, udp and deoD, which are active on deoxyu‑
ridine and thymidine, was not sufficient to block dCyd degradation 
completely. However, after the disruption of both dcd and cdd, dCyd 
degradation was not observed in the in vitro assay. Negative control 
with dCyd (open circle), BL21(DE3) (filled circle), HLC001 (ΔdeoA) (open 
square), HLC003 (ΔdeoA ΔdeoD Δudp) (filled square), HLC004 (ΔdeoA 
ΔdeoD Δudp Δdcd) (open triangle) and HLC005 (ΔdeoA ΔdeoD Δudp 
Δdcd Δcdd) (filled triangle).
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which plays a key role in dTTP synthesis, was disrupted 
in the parental HLC006 strain (Additional file  1: Figure 
S2B). However, because the resulting strain, HLC007, 
had no way to synthesize dTTP due to deletions of thyA, 
deoA, deoD and udp, it could not synthesize dTTP by de 
novo nucleotide synthetic pathway. Afterward, 20  mg/L 
of thymidine was added to all media for complementation 
of growth. Interestingly, in dCyd degradation assay, dCyd 
degradation was still observed in HLC004 strain but not 
in HLC005 strain (Figure  2; Table  1). This result means 
that the possible paths, whereby dCyd can be degraded 
by detouring dCyd to deoxyuridine, were blocked com-
pletely by disrupting cdd as well as dcd.
The elimination of CarAB repressors increases the influx 
of precursors into nucleotide synthesis
E. coli CarAB is controlled tightly by at least five tran-
scription factors. Among known transcription factors, 
PurR, PepA and ArgR are capable of controlling CarAB 
activity by the coordination of intracellular levels of 
arginine and nucleotides [21]. We previously demon-
strated that the disruption of three repressors govern-
ing carAB transcription could be leveraged to enhance 
thymidine production in E. coli [7]. Here, we specu-
lated that the disruption of three repressors govern-
ing carAB transcription could be similarly applied to 
dCyd production. Using HLC007, the repressor genes, 
purR, pepA and argR were deleted sequentially by the 
same deletion method, resulting in HLC010 (Additional 
file 1: Figure S2C). We hypothesized that CarAB activ-
ity in HLC010 might scarcely be affected by intracellular 
nucleotide or nucleoside levels, and subsequently, influx 
of nucleotide precursors could be increased by less reg-
ulation. To test this hypothesis, we analyzed transcrip-
tional levels of genes related to the supply of precursors 
by microarray assay. Not surprisingly, the transcrip-
tion levels of tested genes, which synthesize carbamoyl 
phosphate and aspartate, were increased significantly 
(P < 0.05) (Additional file 1: Table S1), when PurR, PepA 
and ArgR were absent (Figure  3, black colored box), 
indicating that the increase in the supply of major pre-
cursors was caused by enhanced transcriptional levels 
of the tested genes. These results could not completely 
explain these phenomena, however, because we only 
tested a limited number of genes without measuring 
intracellular nucleoside and nucleotide levels. Regard-
less, this result showed that the transcription of carAB 
as well as many genes involved in supplying precursors 
was increased significantly under the same conditions, 
and subsequently dCyd yield was also increased by 1.2 
fold (Figure 4). Taken together, these results supported 
our hypothesis.
Table 1 Strains and plasmids
a Gene Accession: deoA (CAQ34741), udp (CAQ34184), deoD (CAQ34743), purR (CAQ32135), pepA (CAQ34607), argR (CAQ33565), dcd (CAQ32477), cdd (CAQ32548), 
codA (CAQ30812), thyA (CAQ33153), pgi (CAQ34374), yfbR (CAQ32693), pyrG (CAQ33104), T4 nrdA (NP_049845), T4 nrdB (NP_049841), T4 nrdC (NP_049698).
Strain or plasmid Descriptiona Source or reference
Strains
 BL21(DE3) F−ompT hsdSB(rB
−mB
−) gal dcm me131 (DE3) Invitrogen
 XL1‑Blue recA1 endA1 gyrA96 thi‑1 hsdR17 supE44 relA1 lac [F′ proAB lacIqZΔM15 Tn10 (Tetr)] Stratagene
 HLC001 BL21 ΔdeoA This study
 HLC003 BL21 ΔdeoA Δudp ΔdeoD This study
 HLC004 BL21 ΔdeoA Δudp ΔdeoD Δdcd This study
 HLC005 BL21 ΔdeoA Δudp ΔdeoD Δdcd Δcdd This study
 HLC006 BL21 ΔdeoA Δudp ΔdeoD Δdcd Δcdd ΔcodA This study
 HLC007 BL21 ΔdeoA Δudp ΔdeoD Δdcd Δcdd ΔcodA ΔthyA This study
 HLC010 BL21 ΔdeoA Δudp ΔdeoD Δdcd Δcdd ΔcodA ΔthyA ΔpurR ΔpepA ΔargR This study
 HLC015 BL21 ΔdeoA Δudp ΔdeoD Δdcd Δcdd ΔcodA ΔthyA ΔpurR ΔpepA ΔargR Δpgi This study
Plasmids
 pETDuet ColE1 replicon, bla Novagen
 pKD3 Template plasmid, derivative of pANTSγ, FRT‑flanked cat [43]
 pKD20 λ Red helper plasmid, derivative of pINT‑ts, araC‑ParaB and γ β exo DNA fragments [43]
 pCP20 bla and cat, oriTS, thermal inducible FRT recombinase [43]
 pETNG pETDuet T4 nrdCAB operon and pyrG expression under tac promoter, bla This study
 pETNY pETDuet T4 nrdCAB operon and yfbR expression under tac promoter, bla This study
 pETGY pETDuet pyrG operon and yfbR expression under tac promoter, bla This study
 pETNGY pETDuet T4 nrdCAB operon, pyrG and yfbR expression under tac promoter, bla This study
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The overexpression of nucleotide biosynthetic genes 
favors dCyd production
The HLC010 strain was potentially a good host for pro-
ducing dCyd because most of its intrinsic genes related 
to degradation of dCyd and regulation of CarAB were 
deleted. Accordingly, if proper nucleotide biosynthetic 
genes were overexpressed in this host cell, it might be 
a good dCyd producing strain. Considering the overall 
nucleotide biosynthetic pathway (Figure  1), we selected 
three essential steps and their corresponding genes, NDP 
reduction (nrdCAB), UTP amination (pyrG), and dCMP 
hydrolysis (yfbR). The overexpression of NDP reductase 
(NrdCAB) is known as the best way to increase intra-
cellular dNTP level [9]. Also, as the transcription of the 
pyrG gene is regulated by a CTP pool, the overexpression 
of CTP synthetase (PyrG) can overcome the limitation 
of the excessive synthesis of CTP. The overexpression of 
cytidine phosphohydrolase (YfbR) can result in acceler-
ating dCyd synthesis by the demand of dCMP for DNA 
synthesis. In case of NDP reductase, we used T4 NDP 
reductase which was previously used successfully for thy-
midine production [9], instead of E. coli intrinsic enzyme, 
to eliminate possible feedback inhibition by the nucleo-
tide pool.
To test their combinatorial effect on dCyd production, 
T4 nrdCAB +  pyrG, T4 nrdCAB +  yfbR, yfbR +  pyrG, 
and yfbR + pyrG + T4 nrdCAB were each assembled into 






















































Figure 3 Transcriptional change of pyrimidine and arginine biosynthetic genes by disruption of CarAB repressors (PurR, PepA and ArgR). The num‑
bers are the ratios of the expression levels in HLC010 vs. HLC007. The shaded numbers indicate significantly up‑regulated genes in HLC010 (P < 0.05). 
a The transcriptional change of genes for precursor supply and pyr operon. α‑ketoglutarate and oxaloacetate introduced from the TCA cycle might 
be converted quickly into carbamoyl phosphate and aspartate. The resulting increased precursors can enhance the production of dCyd. b The 
transcriptional change of the arg operon. Most of the Arg biosynthetic genes were up‑regulated except for argG. The decrease of argG transcription 
may be the rate‑limiting step for synthesizing arginine. AKG α‑ketoglutarate, OAA oxaloacetate, GLU l‑glutamate, GLN l‑glutamine, CarP carbamoyl 
phosphate, ASP l‑aspartate, C-ASP carbamoyl aspartate, ORO orotate, OMP orotate mono phosphate, NAG N‑acetyl glutamate, NAGP N‑acetyl glu‑
tamate phosphate, NAGsA N‑acetyl glutamate semi aldehyde, NAO N‑acetyl ornithine, ORN ornithine, CITR citrulline, Arg-Suc argino succinate, ARG 
l‑arginine.
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in plasmid, pETDuet. The resulting plasmids, pETNG, 
pETNY pETGY, and pETNGY permitted combinatorial 
co-expression of T4 nrdCAB, yfbR and pyrG (Additional 
file  1: Figure S3). Following expression of each of the 
synthetic combinatorial operons in HLC010 cells (Addi-
tional file 1: Figure S4), we investigated dCyd production 
in flask cultures. In HLC010-pETNG, which overex-
pressed T4 nrdCAB and pyrG, 401  mg/L of dCyd were 
produced in flask culture (Figure 4, Additional file 1: Fig-
ure S5). This dCyd yield was approximately 4-fold greater, 
compared to host cells, HLC010. In addition, HLC010-
pETNY, which overexpressed T4 nrdCAB and yfbR, pro-
duced 410  mg/L of dCyd. These results indicated that 
the overexpression of two genes with distinct roles (nrd-
CAB and yfbR), was more effective than overexpression 
of similar genes related to the supply of cytidine nucleo-
tide (nrdCAB and pyrG). Before testing HLC010-pETGY, 
we investigated dCyd production by HLC010-pETNGY, 
which appeared to be the best strain. In case of HLC010-
pETNGY, which overexpressed T4 nrdCAB, yfbR and 
pyrG, dCyd yield was highly increased to 552  mg/L, as 
expected. However, as dCyd production was increased, 
several byproducts were also increased (Additional file 1: 
Figure S5F). In contrast, in case of HLC010-pETGY, 
which overexpressed only yfbR and pyrG, the quantity 
of byproducts was decreased in the HPLC profile, com-
pared to HLC010-pETNGY. In return, dCyd production 
yield of HLC010-pETGY was increased to 650  mg/L, 
with less byproduct formation (Figure 4, Additional file 1: 
Figure S5G). In HLC010-pETGY, most of the distinct 
peaks were decreased in the HPLC profile, compared to 
HLC010-pETNGY.
The yield of dCyd can be improved by disrupting pgi 
in HLC010‑pETGY
Eliminating pgi, a gene necessary for the EMP pathway, 
completely blocks isomerization of glucose 6-phosphate 
to fructose 6-phosphate, detouring the metabolism of 
glucose to the pentose phosphate (PP) pathway. Since 
the main role of the PP pathway is to supply NADPH and 
ribose, shifting metabolism towards this pathway could 
increase NADPH levels and ribose precursor in cells [7]. 
The disruption of pgi in HLC010 was performed using 
a linear PCR fragment with 50 nucleotides of homology 
extensions to construct strain HLC015 (Additional file 1: 
Figure S3D). The best plasmid, pETGY, as determined 
above, was used to transform HLC015 cells. In this 
experiment, we needed to change the carbon source in 
the medium from glycerol to glucose, because HLC015-
pETGY cannot use glycerol efficiently via the PP pathway. 
HLC015-pETGY did not grow in production medium 
with glycerol, and likewise, HLC010-pETGY showed 
decreased growth in production medium with glucose. 
Accordingly, to compare these two strains, we used the 
optimal cultivation medium for each. Under these con-
ditions, HLC010-pETGY produced 650  mg/L of dCyd 
in the production medium with glycerol, and HLC015-
pETGY produced 967  mg/L of dCyd in the production 
medium with glucose during similar cultivation times (30 
and 32 h, respectively) (Figure 5). Generally, pgi disrup-
tion prevents or delays the normal utilization of glucose 
in cells, which retards cell growth due to a limited capac-
ity for the re-oxidation of overproduced NADPH [23, 
24]. However, in HLC015-pETGY, the retardation of cell 
growth was not observed, suggesting that the over-accu-
mulation of NADPH and ribose precursors was alleviated 
due to NADPH-recycling and ribose consumption during 
dCyd overproduction. Interestingly, the byproduct peaks 
also disappeared or considerably decreased in HPLC pro-
files of the broth supernatant (Additional file  1: Figure 
S5H). In return, the dCyd production yield of HLC015-
pETGY was considerably increased, which could also be 
seen as increased yield caused by decreasing the byprod-
ucts. One of our objectives was to prepare a high dCyd 
producer with no byproducts like deoxyuridine, cytosine, 
uracil or thymine, while retaining the ability to produce 
dCyd. Even though the optimization of overall fermen-
tation processes is still required, dCyd production was 
achieved successfully without significant co-produced 







































































Figure 4 dCyd production by all engineered BL21 derivative strains. 
Seed cultures were grown in 5 mL of Luria–Bertani media overnight, 
and then transferred to 500‑mL baffled flasks containing 50 mL 
of production media (see “Methods”). The strains carrying expres‑
sion plasmids were induced for protein expression with isopropyl 
β‑d‑1‑thiogalactopyranoside (IPTG; 0.5 mM) when cells reached 
OD600 ≈ 0.6. All flask cultures were incubated at 37°C and 250 rpm 
for 36 h. The dCyd concentration in the media was determined from 
the supernatants of cultivation samples. Values are mean ± SD of 
triplicate flasks experiments performed at the same time.
Page 7 of 11Kim et al. Microb Cell Fact  (2015) 14:98 
engineered cells for developing industrial dCyd produc-
tion and purification processes.
Discussion
In this study, we developed promising dCyd produc-
ing strains by metabolic reprogramming of E. coli, based 
on recent information on pyrimidine metabolism and 
uncovered the metabolic change in our cells by transcrip-
tome analysis. Specifically, the remarkable feature of our 
strain is that the approach produced the reduced form 
of cytidine by controlling regulations as well as pathway 
recombineering. Indeed, dCyd production by rational 
design was relatively more difficult than the oxidized 
form in terms of reducing power regeneration as well 
as supply of precursors. In this study, to complement a 
reducing power in all strains but HLC015-pETGY, glyc-
erol was used as carbon source instead of glucose. We 
were supposed that HLC015-pETGY also had higher 
NADPH/NADP ratio than other strains, because glu-
cose can be passed through PP pathway with generating 
NADPH, but glycerol cannot. In similar case of previ-
ous study for developing thymidine producer, we have 
obtained the supporting data that NADPH/NADP ratio 
of pgi-disrupting cells showed higher level in continuous 
Time (h)








































































Figure 5 Cultivation profiles of HLC010‑pETGY and HLC015‑pETGY in flask scale. HLC015‑pETGY showed slower growth rate but higher productiv‑
ity than HLC010‑pETGY by additional pgi deletion. a Fermentation profile using HLC010‑pETGY. Glycerol was used as the carbon source. b Fermen‑
tation profile using HLC015‑pETGY. Glucose, at a concentration (60 g/L) equivalent to that of cultures with glycerol, was used as the carbon source. 
Values are mean ± SD from three independent experiments performed in triplicate.
Page 8 of 11Kim et al. Microb Cell Fact  (2015) 14:98 
culture with glucose, while NADH/NAD ratio showed 
lower, compared to those of parental cells in continuous 
culture with glycerol [11]. The fermentation using glyc-
erol has an advantage of producing extra NADH, which 
can be easily converted into NADPH in the presence of 
extra phosphate [13, 25, 26]. In addition, its effect can 
be amplified by overexpressing intrinsic NAD kinase or 
soluble transhydrogenase [10, 11, 27, 28]. While there 
are less supporting data as to which approach is more 
efficient between PP pathway rerouting and glycerol fer-
mentation, both approaches highlight the importance of 
supplying reducing power.
Interestingly, HPLC analysis of the culture superna-
tants of HLC010-pETNGY and HLC010-pETGY broth 
revealed the formation of byproducts in addition to dCyd 
production (Additional file  1: Figure S5), which poten-
tially lowers dCyd productivity and makes downstream 
purification processes difficult. HLC010-pETGY showed 
higher productivity, compared to HLC010-pETNGY, 
and co-produced less byproducts (Figure 4). One possi-
ble explanation is that the excessive reduction of UDP by 
strong overexpression of T4 NDP reductase might have 
a negative effect on UTP amination by PyrG. In the case 
of HLC010-pETNGY, NDP reductase was overexpressed 
without any regulation, probably acting to convert 
more UDP into dUDP, while simultaneously decreas-
ing the UTP supply for conversion to CTP by PyrG. 
Subsequently, excess dUMP can be readily degraded 
into deoxyuridine by YfbR, which has higher activity on 
dUMP by twofold compared to dCMP [19], because there 
is no pathway to convert deoxyuridine and dUTP into 
deoxycytidine and dCTP, respectively, in HLC010 cells 
where dcd, cdd and codA were deleted. In contrast, in 
HLC010-pETGY cells, more UTP can be converted into 
CTP by the expressed PyrG than in HLC010-pETNGY 
cells. Thus, if we express a dCMP phosphohydrolase 
with higher affinity for dCMP than yfbR, the simultane-
ous expression of a NDP reductase might be effective to 
improve productivity.
In HLC015-pETGY, more NADPH and ribose precur-
sors were supplied by rerouting from the EMP pathway 
to the PP pathway, compared to HLC010-pETGY. The 
PyrG-associated supply of sufficient precursors and 
redox potential could have given rise to the increased 
dCMP/dUMP ratio of HLC015-pETGY cells, leading 
to enhanced dCMP hydrolysis by YfbR. In support of 
this, we obtained several lines of evidence that byprod-
uct formation was further decreased when YfbR was 
expressed under control of the T7 promoter, compared to 
the arabinose promoter (data not shown). While further 
experiments are needed to clearly explain the relation-
ship of YfbR activity and dCyd biosynthesis, we postu-
late that the balance between YfbR and PyrG activity 
may be very closely linked to byproduct formation in 
HLC010-pETGY.
In further engineering, the complete elimination of 
degradation enzymes with broad activity may be very 
important in further developing a dCyd producer, 
because dCyd is released to the media, instead of accu-
mulating inside cells. While not investigated here, it is 
possible that ribonucleoside hydrolases and analogues, 
RihA, RihB, and RihC may be involved in dCyd nicking 
via an unknown mechanism [29]. This would explain 
how residual nucleoside byproducts still existed in vivo, 
even though the in vitro dCyd degradation assay showed 
HLC005 appeared to block dCyd hydrolysis completely. 
The contribution of RihA, B, and C for byproduct for-
mation remains to be examined in  vivo. Nonetheless, 
this potential activity of RihA, B, and C is not entirely 
unexpected in light of the other degradation enzymes 
for dCyd (or Cyd). For example, a pyrimidine requiring 
cdd mutant of E. coli can utilize cytidine as a pyrimidine 
source by an alternative pathway, which involves hydroly-
sis of cytidine by RihA, B, and C [29]. Likewise, RihA, B, 
and C are predicted to fulfill degradation roles for dCyd/
Cyd in our cells by participating in the salvage pathway.
As mentioned, CarAB is controlled by at least five tran-
scription factors [30, 31]. Among these repressors, those 
encoded by purR, pepA, and argR are known as repre-
sentative binders to the carAB promoter P1 (upstream) 
and P2 (downstream), which are adjacent to each other 
[32]. PurR and ArgR repress transcription by binding to 
each carAB promoter P1 and P2, respectively. In contrast, 
PepA shares a binding site with PurR and ArgR partially, 
so it influences regulation of both promoters. Accord-
ing to previous study, in the case of purine metabolism 
in purR-deficient cells, genes related to ribose moiety 
supply and the flux into IMP, are generally increased but 
genes related to AMP or GMP biosynthesis from IMP are 
decreased in expression [21]. By eliminating argR, many 
genes in arginine and aspartate biosynthesis, which are 
directly regulated by the ArgR repressor, are up-regulated 
[33–35]. Likewise, the third repressor PepA influences 
both metabolism and the intracellular nucleotide pool. 
However, the simultaneous disruption of purR, pepA and 
argR may appear to give cells more complex metabolic 
changes in nucleotide metabolism and arginine metabo-
lism, compared to the separate one gene disruption.
The arginine biosynthetic pathway is competitive with 
the pyrimidine biosynthetic pathway in utilizing car-
bamoyl phosphate [21, 33]. If arginine overproduction 
occurred in our strain, this would be disadvantageous 
to pyrimidine biosynthesis. However, in this study, we 
did not observe arginine overproduction in the three 
repressor-deficient cells, while dCyd overproduction was 
observed. Interestingly, down-regulation of ArgG in the 
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three repressor-deficient cells was observed. One pos-
sible explanation for this is that the down-regulation of 
ArgG may resulted from co-disruption of pepA/purR 
and amplification of other nucleotide synthetic pathways 
in HLC010. This would explain why previous studies, 
which all involved argR regulation but not co-disruption 
of pepA and purR, did not observe argG down-regula-
tion. Even though we cannot explain the clearly complex 
regulation in the recombineered cells, it is plausible that 
the decrease of ArgG expression in the three repressor-
deficient cells slowed the conversion rate of carbamoyl 
phosphate into the arginine precursor, thereby enabling 
metabolism of carbamoyl phosphate mainly via the 
pyrimidine pathway.
As shown in Figure  3a, expression of pyrBI, pyrC, 
pyrD and pyrE were kept off or slightly down-regulated 
in HLC010, which is consistent with the earlier observa-
tion that these genes are kept off even in the absence of 
the repressors encoded by purR, pepA and argR, through 
attenuation control by coupled transcription and trans-
lation [36]. We speculate that this attenuation might be 
the result of increased intracellular UTP and CTP levels 
that arise in the metabolically engineered strain. In sup-
port of this notion, the transcription of pyrBI and pyrE 
are controlled negatively by UTP-sensitive attenuation 
[37–39]. Additionally, the transcription of pyrBI is regu-
lated by reiterative transcription at high UTP levels [40]. 
Translation of pyrC is controlled negatively by prevent-
ing ribosome binding to the Shine–Dalgarno (SD) box 
via shifting transcription start sites at high CTP levels 
[41, 42]; pyrD may be regulated by a similar mechanism 
[43]. Such UTP- and CTP-sensitive regulation of these 
genes might limit pyrimidine biosynthesis, even when the 
supply of precursors and the downstream dCyd flux are 
increased. Despite severe UTP- and CTP-sensitive regu-
lation, the additional overexpression of genes of the pyr 
operon in our cells may be a reliable approach.
Conclusions
From a technological standpoint, a notable outcome 
of the studies described here was the preparation of a 
dCyd producing strain with fewer byproducts by rational 
metabolic engineering. We demonstrated that high 
dCyd yield could be readily achieved by recombineer-
ing in combination with disruption of dCyd degrading 
enzymes and repressors for carbamoyl phosphate syn-
thetase, and amplification of dCyd synthesis enzymes. 
In addition, we showed that carbon flux rerouting by 
disrupting pgi, was a very efficient approach in our cells. 
In particular, we showed how nucleotide metabolic flow 
was changed by microarray analysis, which could easily 
be leveraged for further improvement of the dCyd-pro-
ducing strain.
Methods
Bacterial strains and growth conditions
All strains used in this study are shown in Table 1. Paren-
tal strain E. coli BL21(DE3) was used for preparing 
dCyd producing strains. To eliminate the possibility of 
dCyd degradation by endogenous nucleosides degrada-
tion enzymes, a triple knockout strain was prepared by 
sequential knockout of deoA, udp and deoD in BL21(DE3) 
by PCR mediated gene disruption as described previously 
[44]. The first-step generated strain HLC003, which was 
then subject to disruption of genes encoding branching 
enzymes (dcd, cdd, codA and thyA), followed by removal 
of the chloramphenicol marker (Cm) in each target gene 
using pCP20 by the same method. The resulting strain, 
HLC007 was then subject to disruption of genes encod-
ing the CarAB repressors (purR, pepA and argR), result-
ing in strain HLC010. Finally, the pgi gene of HLC010 
was knocked out by the described method, resulting in 
strain HLC015 (BL21(DE3) ΔdeoA Δudp ΔdeoD Δdcd 
Δcdd ΔcodA ΔthyA ΔpurR ΔpepA ΔargR Δpgi::Cm). E. 
coli XL1-Blue was used for cloning genes.
Typically, cultures were grown in Luria–Bertani (LB) 
medium supplemented with antibiotic as needed. Antibi-
otics were provided at the following concentrations: chlo-
ramphenicol (Cm), 20 μg/mL; ampicillin (Amp), 100 μg/
mL.
For dCyd production experiments, a suspension of cells 
was inoculated into a 250 mL flask containing 50 mL of 
LB medium and incubated at 37°C and 250 rpm for 8 h. 
For flask culture, 5 mL of culture broth was transferred 
to a 500-mL baffled flask containing 50 mL of production 
medium (60  g/L glycerol (glucose in case of HLC015), 
10 g/L CaCO3, 10 g/L yeast extract, 0.4 g/L MgSO4·7H2O, 
14.84 g/L soytone, 100 μg/mL ampicillin, and trace ele-
ments) and 0.5 mM IPTG for induction, and then incu-
bated at 37°C and 250 rpm for 36 h.
Plasmid construction
All plasmids used in this study are listed in Table 1 and all 
primer sequence used for constructing vectors are listed 
in Additional file 1: Table S2. For expression of the dCyd 
biosynthetic genes T4 nrdCAB, pyrG and yfbR, plasmid 
pETDuet (Novagen) was used in this study. To generate 
plasmids pETNG and pETNY, PCR-amplified T4 nrdB 
(P23 and P24) was cloned into the NcoI/SalI restriction 
sites of pETDuet, and then PCR-amplified pyrG and yfbR 
(P27 and P28) were cloned into the NdeI/XhoI restriction 
sites, respectively. PCR-amplified T4 RBS-nrdCA (P25 and 
P26) was then ligated into each of the above plasmids using 
the SalI restriction site (Additional file 1: Figure S3A, B). 
Plasmid pETGY was generated by inserting PCR-amplified 
pyrG (P29 and P30) into the NcoI/SalI restriction sites 
and then inserting PCR-amplified yfbR (P31 and P32) into 
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the NdeI/XhoI restriction sites of pETDuet (Additional 
file  1: Figure S3C). To generate the plasmid pETNGY, 
PCR-amplified T4 nrdB (P23 and P24) was inserted into 
the NcoI/SalI restriction sites of pETDuet and then PCR-
amplified pyrG (P27 and P28) was cloned into the NdeI/
XhoI restriction sites. PCR-amplified RBS-yfbR (P33 and 
P32) was inserted into the XhoI restriction site of the 
resulting plasmid. After checking gene orientation, PCR-
amplified T4 RBS-nrdCA (P25 and P26) was ligated into 
the SalI restriction site (Additional file 1: Figure S3B, D). 
All plasmids were confirmed by DNA sequencing.
In vitro dCyd degradation assay
Equal amounts of transformed cells were harvested by 
centrifugation and washed with 10  mM Tris (pH 7.4) 
containing a protease inhibitor mixture (Complete™, 
Amersham Phamacia). Each enzyme solution was pre-
pared by sonication and its protein concentration was 
determined by the Lowry assay. For the enzyme assay, 
100 μL of 1 mM dCyd was mixed with 100 μL of enzyme 
solution (1.2 mg/mL) and the reaction mixture was incu-
bated at 30°C for 16  h with sampling for analysis (1, 3, 
and 13 h). Then enzyme reaction was stopped by the fil-
tration with PVDF and the residual thymidine concentra-
tion was measured in the reaction mixture.
Transcriptome analysis
Total cellular RNA was extracted from mid-log phase 
cells with a QIAGEN RNEasy Mini Kit (Qiagen, Valen-
cia, CA, USA) as described by the manufacturer. RNase-
free DNaseI (Takara Bio, Shiga, Japan) was used during 
the isolation procedure to eliminate possible DNA con-
tamination. cDNA probes for cDNA microarray analysis 
were prepared by the reverse-transcription of total RNA 
(25 μg) in the presence of aminoallyl-dUTP and 6 μg of 
random primers (Invitrogen, Carlsbad, CA) for 3 h. The 
cDNA probes were cleaned up using Microcon YM-30 
columns (Millipore, Bedford, MA, USA) and then cou-
pled to Cy3 dye (for reference HLC007) or Cy5 dye (for 
test sample HLC010) (Amersham Pharmacia, Uppsala, 
Sweden). The Cy3- or Cy5-labeled cDNA probes were 
purified with QIAquick PCR Purification Kit (Qiagen, 
Valencia, CA). Dried Cy3- or Cy5-labeled cDNA probes 
were resuspended in hybridization buffer (30% forma-
mide, 5X SSC, 0.1% SDS, and 0.1 mg/mL salmon sperm 
DNA). The Cy3- or Cy5-labeled cDNA probes were 
mixed together and hybridized to a customized microar-
ray slide (Mycroarray.com, Ann Arbor, MI, USA). After 
washing and drying slide, which was scanned by Axon 
4000B (Axon Instrument, Union City, CA, USA) to gen-
erate hybridization images.
Hybridization images were analyzed by GenePix Pro 
3.0 software (Axon Instrument, Union City, CA, USA) 
to obtain gene expression ratios (M value = (Cy5 signal-
HLC010 − background)/(Cy3 signalHLC007 − background)). 
Microarray data analysis was carried out by Genowiz 
4.0™ (Ocimum Biosolutions, India). The mean signal 
intensity values of the duplicate spots were averaged (A 
value  =  [(Cy5 signalHLC010  −  background)  +  (Cy3 sig-
nalHLC007 − background)]/2) and then normalized by the 
global normalization method.
Analytical methods
Biomass measured by the OD600 was converted to DCW 
using a standard curve (1.0 OD600 = 0.45 gdcw/L). Quan-
titative determinations of bases and nucleosides were 
performed by HPLC with modifying previous condition 
for thymidine [9]. The operating conditions were as fol-
lows: column, Zorbax SB-C18, 5  μm (4.6  ×  150  mm) 
(Agilent Co., Ltd., Santa Clara, CA, USA); solvent, 1% 
(v/v) acetonitrile in water; flow rate, 1 mL/min; detection 
at 265 nm. All standards for HPLC were purchased from 
Sigma.
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